查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1545567

全球陣列設備市場

Array Instruments
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球陣列設備市場預計將達27億美元

2023年全球陣列設備市場預計為19億美元，預計到2030年將達到27億美元，2023-2030年分析期間複合年成長率為5.3%。 DNA 微陣列技術是本報告分析的細分市場之一，預計複合年成長率為 5.4%，到分析期結束時將達到 14 億美元。分析期間，蛋白質微陣列技術領域的複合年成長率預計為 5.8%。

美國市場預估為5.076億美元，中國預期複合年成長率為5.1%

預計2023年美國陣列設備市場規模將達5.076億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到4.227億美元，2023年至2030年複合年成長率為5.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 5.1% 和 4.1%。在歐洲，德國的複合年成長率預計為 4.4%。

全球陣列設備市場 - 主要趨勢與促進因素總結

陣列設備如何徹底改變生物醫學研究？

陣列儀器在分析複雜的生物資料方面提供了前所未有的能力，並已成為生物醫學研究領域的重要工具。這些儀器，包括 DNA 微陣列、蛋白質陣列和組織陣列，使研究人員能夠同時研究數千個基因、蛋白質和其他生物分子的表現。陣列儀器的高通量性質徹底改變了科學家研究基因體學、蛋白質體學和個人化醫療的方式，以實現更全面、更準確的分析。陣列設備可以輕鬆地同時研究多種生物標記物，從而加快了癌症研究、遺傳疾病和藥物開發等領域的發現步伐。快速準確評估基因表現模式和蛋白質相互作用的能力使這些儀器成為現代實驗室業務的基石，從而在了解疾病機制和潛在治療標靶方面取得重大進展。

增強陣列設備能力的技術創新有哪些？

不斷的技術創新推動了陣列設備的發展，這些創新擴大了陣列設備的功能和應用範圍。微陣列技術的最新進展提高了這些儀器的靈敏度、特異性和解析度，使它們能夠檢測基因和蛋白質表現的最小變化。此外，先進計算工具的整合提高了資料分析能力，使研究人員能夠更準確、更有效率地解釋複雜的資料集。陣列設計的創新，例如高密度陣列的開發，進一步提高了這些設備的吞吐量，使它們比以往任何時候都更強大。此外，可以同時分析多種類型生物分子的多重陣列的出現開闢了新的研究途徑，特別是在系統生物學領域。這些技術進步不僅提高了陣列元件的性能，而且擴大了其應用範圍，使其在從基礎科學到臨床診斷的廣泛研究領域中不可或缺。

為什麼陣列設備對於個人化醫療和診斷很重要？

陣列設備在個人化醫療和診斷的發展中發揮著至關重要的作用，其中精確度和準確性至關重要。陣列設備徹底改變了疾病的診斷和治療方式，因為它們可以提供個別患者的詳細分子特徵。在個人化醫療中，陣列設備用於識別特定的基因突變和表達模式，從而預測患者對特定治療的反應，從而實現更量身定做和有效的治療策略。診斷能夠檢測指示癌症、心血管疾病和自體免疫疾病等疾病的存在或進展的生物標記。在臨床實踐中採用陣列設備將有助於從一刀切到個人化護理的轉變，從而改善患者的治療效果並降低醫療成本。隨著對個人化醫療保健解決方案的需求持續成長，陣列設備在研究和臨床環境中的重要性預計將顯著成長。

陣列設備市場成長的驅動力是什麼？

陣列設備市場的成長是由影響其擴張和發展的多個因素所推動的。一個關鍵促進因素是生物醫學研究中對高通量技術的需求不斷成長，其中需要快速、準確地分析大型資料集。個人化醫療的興起也對市場成長做出了重大貢獻。醫療保健提供者正在尋求先進的分子診斷工具和量身定做的治療策略。下一代微陣列的開發以及人工智慧和機器學習在資料分析中的整合等技術進步透過提高這些儀器的功能和效率進一步推動了市場。陣列設備在癌症研究、藥物開發和農業生物技術等領域的廣泛應用正在為市場成長創造新的機會。此外，人們越來越重視疾病的早期發現和精準醫療的發展，陣列設備擴大應用於臨床診斷，特別是在醫療基礎設施發達的已開發國家。隨著這些趨勢的不斷發展，在創新以及研究和醫療保健領域對先進分析工具日益成長的需求的推動下，陣列設備市場有望實現持續成長。

受訪企業範例（共43例）

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings（LabCorp）
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC.
  • MilliporeSigma
  • Mingyuan Medicare Development Company Limited
  • Molecular Devices LLC
  • Novus Biologicals LLC
  • OriGene Technologies, Inc.
  • Orla Protein Technologies Ltd.
  • Oxford Gene Technology
  • Partek, Inc.
  • Pepscan
  • PerkinElmer, Inc.
  • Phalanx Biotech Group
  • ProteoGenix
  • Qiagen NV
  • RayBiotech, Inc.
  • Retrogenix Ltd.
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP10375

Global Array Instruments Market to Reach US$2.7 Billion by 2030

The global market for Array Instruments estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. DNA Microarrays Technology, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Protein Microarrays Technology segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$507.6 Million While China is Forecast to Grow at 5.1% CAGR

The Array Instruments market in the U.S. is estimated at US$507.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$422.7 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Array Instruments Market - Key Trends and Drivers Summarized

How Are Array Instruments Revolutionizing Biomedical Research?

Array instruments have become indispensable tools in the field of biomedical research, offering unprecedented capabilities in analyzing complex biological data. These instruments, which include DNA microarrays, protein arrays, and tissue arrays, enable researchers to study the expression of thousands of genes, proteins, or other biomolecules simultaneously. The high-throughput nature of array instruments has transformed the way scientists approach genomics, proteomics, and personalized medicine, allowing for more comprehensive and precise analyses. By facilitating the simultaneous examination of multiple biomarkers, array instruments have accelerated the pace of discovery in areas such as cancer research, genetic disorders, and drug development. The ability to quickly and accurately assess gene expression patterns and protein interactions has made these instruments a cornerstone of modern laboratory practices, leading to significant advancements in our understanding of disease mechanisms and potential therapeutic targets.

What Technological Innovations Are Enhancing the Capabilities of Array Instruments?

The evolution of array instruments has been driven by continuous technological innovations that have expanded their functionality and application scope. Recent advancements in microarray technology have increased the sensitivity, specificity, and resolution of these instruments, enabling the detection of even minute changes in gene or protein expression. Additionally, the integration of advanced computational tools has enhanced data analysis capabilities, allowing researchers to interpret complex datasets with greater accuracy and efficiency. Innovations in array design, such as the development of high-density arrays, have further increased the throughput of these instruments, making them more powerful than ever before. Moreover, the emergence of multiplexed arrays, which can analyze multiple types of biomolecules simultaneously, has opened new avenues for research, particularly in the field of systems biology. These technological strides have not only improved the performance of array instruments but have also broadened their applicability, making them essential in a wide range of research areas, from basic science to clinical diagnostics.

Why Are Array Instruments Critical in Personalized Medicine and Diagnostics?

Array instruments play a pivotal role in the advancement of personalized medicine and diagnostics, where precision and accuracy are paramount. The ability of these instruments to provide detailed molecular profiles of individual patients has revolutionized the way diseases are diagnosed and treated. In personalized medicine, array instruments are used to identify specific genetic mutations or expression patterns that can predict a patient’s response to certain therapies, allowing for more tailored and effective treatment strategies. In diagnostics, these instruments enable the detection of biomarkers that can indicate the presence or progression of diseases such as cancer, cardiovascular conditions, and autoimmune disorders. The adoption of array instruments in clinical settings has facilitated the transition from one-size-fits-all treatment approaches to more individualized care, improving patient outcomes and reducing healthcare costs. As the demand for personalized healthcare solutions continues to grow, the importance of array instruments in both research and clinical practice is expected to increase significantly.

What Is Driving the Growth of the Array Instruments Market?

The growth in the array instruments market is driven by several factors that are shaping its expansion and evolution. A key driver is the increasing demand for high-throughput technologies in biomedical research, where the need to analyze large datasets quickly and accurately is paramount. The rise of personalized medicine has also significantly contributed to market growth, as healthcare providers seek advanced tools for molecular diagnostics and tailored treatment strategies. Technological advancements, such as the development of next-generation microarrays and the integration of AI and machine learning in data analysis, are further propelling the market by enhancing the capabilities and efficiency of these instruments. The expanding application of array instruments in areas such as cancer research, drug development, and agricultural biotechnology is creating new opportunities for market growth. Additionally, the growing emphasis on early disease detection and the development of precision medicine are driving the adoption of array instruments in clinical diagnostics, particularly in developed countries with advanced healthcare infrastructures. As these trends continue to evolve, the array instruments market is poised for sustained growth, driven by innovation and the expanding need for sophisticated analytical tools in both research and healthcare.

Select Competitors (Total 43 Featured) -

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC.
  • MilliporeSigma
  • Mingyuan Medicare Development Company Limited
  • Molecular Devices LLC
  • Novus Biologicals LLC
  • OriGene Technologies, Inc.
  • Orla Protein Technologies Ltd.
  • Oxford Gene Technology
  • Partek, Inc.
  • Pepscan
  • PerkinElmer, Inc.
  • Phalanx Biotech Group
  • ProteoGenix
  • Qiagen NV
  • RayBiotech, Inc.
  • Retrogenix Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Array Instruments - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Technologies Spurs Growth of Array Instruments
    • Technological Advancements in Microarray Design Expands Addressable Market Opportunity
    • Increasing Application in Cancer Research Propels Growth in Array Instruments Market
    • Advancements in Multiplexed Arrays Generate Opportunities for Systems Biology Research
    • Growing Focus on Early Disease Detection Throws the Spotlight on Clinical Diagnostics
    • Expansion of Genomic Research Drives Adoption of Next-Generation Microarrays
    • Growing Need for Comprehensive Biomarker Analysis Drives Innovation in Array Technologies
    • Increased Use of Arrays in Agricultural Biotechnology Expands Application Scope
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Clinical Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Array Instruments Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Protein Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION